Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program
Crossref DOI link: https://doi.org/10.1007/s12031-014-0443-z
Published Online: 2014-10-19
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jafarzadeh, A.
Jamali, M.
Mahdavi, R.
Ebrahimi, H. A.
Hajghani, H.
Khosravimashizi, A.
Nemati, M.
Najafipour, H.
Sheikhi, A.
Mohammadi, M. M.
Daneshvar, H.
Text and Data Mining valid from 2014-10-19